Evidence map›Paper›PMID 40603488›Full record

ArticleScientific reports2025

The deleterious effect of WHO grade II diffuse glioma on socioeconomic status as evaluated through occupation.

Matthew A Kirkman, Michael S C Thomas, Andrew Tolmie

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew A KirkmanDepartment of Psychology and Human Development, UCL Institute of Education, University College London, 25 Woburn Square, London, WC1H 0AA, UK. matthew.kirkman.17@ucl.ac.uk.
Michael S C ThomasDepartment of Psychological Sciences, Birkbeck, University of London, London, UK.
Andrew TolmieDepartment of Psychology and Human Development, UCL Institute of Education, University College London, 25 Woburn Square, London, WC1H 0AA, UK.

Funding

Economic and Social Research Council ES/P000592/1
6 · The paper itself

Abstract

Although previous studies have evaluated return-to-work status following low-grade glioma (LGG) treatment, there is a paucity of detailed data on the nature of the occupation a patient returns to. The aim of this study was to describe the socioeconomic status of patients with WHO grade II diffuse glioma over long-term follow up and whether it changed following the LGG diagnosis. In addition, cognitive, education, and quality of life profiles, as well as estimated premorbid intelligence, were evaluated to explore the possibility of relationships with socioeconomic status. Twenty-one individuals with a histological diagnosis of WHO grade II diffuse glioma were recruited prospectively from a single UK center and completed questionnaires evaluating general health, socioeconomics, education, quality of life, and a battery of validated cognitive tests. Socioeconomic status was evaluated through an occupational-based classification. Forty percent of participants in the most advantaged socioeconomic group prior to the diagnosis of a glioma did not remain in the same advantaged group at the point of recruitment into the study. This is despite no marked cognitive impairments across the cohort and no significant cognitive differences between those who did and did not remain in this advantaged group. Attainment of a university-level qualification was significantly associated with maintenance of socioeconomic advantage following the LGG diagnosis, which may be explained by the concept of cognitive reserve. In conclusion, there are profound deleterious socioeconomic effects of LGG and its treatment. Educational attainment may be protective. Early tailored and proactive professional support regarding work-related issues is required for this patient group.

Indexed as

Brain NeoplasmsGliomaOccupationsSocial ClassAdultFemaleHumansMaleMiddle AgedNeoplasm GradingProspective StudiesQuality of LifeSurveys and QuestionnairesCognitive outcomesEducational attainmentLow-grade gliomaQuality of lifeSocioeconomic status

Identifiers

PMID40603488
PMCPMC12222844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.